同仁堂 (600085)
Beijing Tongrentang Co., Ltd.
K-Line Chart
No K-line data available
Company NameBeijing Tongrentang Co., Ltd.
Listing Date1997-06-25
Issue Price7.08RMB
Registered Capital137147.026210k RMB
Legal RepresentativeDi Shubing
Registered AddressNo. 33, Tiangui Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing
IndustryTraditional Chinese Medicine II
Main BusinessProcessing and manufacturing of Chinese patent medicines, operation of Chinese and Western pharmaceuticals.
Company ProfileBeijing Tongrentang Co., Ltd. was established as a joint-stock company by way of public offering, initiated solely by China Beijing Tongrentang (Group) Co., Ltd. with the approval of the Beijing Municipal Economic System Reform Commission. The company was founded on June 18, 1997, and was officially listed on the Shanghai Stock Exchange on June 25 of the same year. In 2012, in accordance with the overall deployment of the Group Company, Beijing Tongrentang Shares (Group) was established.
Stock Details
1. Key Indicators
- Total Shares(W): 137147.03
- Circulating A-Shares(W): 137147.03
- Earnings Per Share(RMB): 0.8590
- Net Assets Per Share(RMB): 9.9626
- Operating Revenue(W RMB): 1330791.48
- Total Profit(W RMB): 195914.60
- **Net Profit Attributable to Parent(W RMB) **: 117755.58
- Net Profit Growth Rate(%): -12.78
- Weighted Return on Equity(%): 8.7200
- Operating Cash Flow Per Share(RMB): 1.4490
- Undistributed Profit Per Share(RMB): 6.4733
- Capital Reserve Per Share(RMB): 1.4220
2. Main Business
The main business covers:
- Pharmaceutical manufacturing
- Traditional Chinese medicine production and sales
3. Company Basic Information
- Company Name: Beijing Tongrentang Co., Ltd.
- Listing Date: 1997-06-25
- Industry: Pharmaceutical Manufacturing
- Address: No. 33 Tiangui Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing
- Website: gf.tongrentang.com
- Company Profile: The company's predecessor was China Beijing Tongrentang Group Company. In 1997, it converted its production and operating net assets into 150 million state-owned legal person shares. After the issuance on May 29, 1997, the total share capital reached 200 million shares. Its 5 million internal employee shares will be listed six months after the 45 million public shares were listed on June 25, 1997.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Beijing Tongrentang (Group) Co., Ltd. | General Legal Person | 71930.85 | 52.45 |
| 2 | China Securities Finance Co., Ltd. | Special Legal Person | 4103.38 | 2.99 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 1534.94 | 1.12 |
| 4 | Huatai-Pinebridge CSI 300 ETF | Fund | 1179.20 | 0.86 |
| 5 | Ruizhong Life Insurance Co., Ltd. - Own Funds | Insurance | 1023.39 | 0.75 |
| 6 | E Fund CSI 300 Healthcare ETF | Fund | 859.42 | 0.63 |
| 7 | E Fund CSI 300 ETF | Fund | 843.89 | 0.62 |
| 8 | Shanghai Gaoyi Asset Management Partnership - Gaoyi Linshan No.1 Yuanwang Fund | General Legal Person | 650.00 | 0.47 |
| 9 | ChinaAMC CSI 300 ETF | Fund | 629.78 | 0.46 |
| 10 | Harvest CSI 300 ETF | Fund | 542.88 | 0.40 |
5. Concept Sectors
- Generic Drugs
- DeepSeek
- Margin Trading & Securities Lending
- Insurance Heavy Positions
- Blue Chip Stocks
- China Securities Finance & Central Huijin
- MSCI Constituent
- Non-Cyclical Stocks
- SSE 180
- SSE Mid Cap
- CSI 300
- CCTV 50
- CSI 200
- CSI 300 Non-Cyclical
- SOE Reform
Remarks
- Data update date: 2025-10-30
- Data source: Public market information